The Transplant Diagnostics market is expected to grow from USD 3.81 billion in 2019 to USD 6.85 billion by 2026 at a CAGR of 7.63% from 2020 to 2026.
The transplant diagnostic is the process of engraftment of organs, tissue, and cell from one body part to another part. Sometimes it is received from the donor to replace the failed organ of the recipient. The global market is segregated on the basis of Technology as Molecular Assay, PCR-based Molecular Assay, and Sequencing-based Molecular Assay. Based on Products & services the market is segmented in Reagents & Consumables, Instruments, and Software & Services. Based on Application the market is segmented in Diagnostic Applications, Pre-transplantation Diagnostics, and Post-transplantation Diagnostics. Based on End User, the market is segmented in independent Reference Laboratories, Hospitals & Transplant Centers, and Research Laboratories & Academic Institutes.
The global market report provides geographical analysis covering regions, such as North America, Europe, Asia-Pacific, and the Rest of the World. The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Abbott Laboratories Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche, Ltd., Illumina, Inc., Immucor, Inc., Linkage Biosciences, Olerup Ssp Ab, Qiagen N.V., Thermo Fisher Scientific Inc., Sigma-Aldrich, and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global Transplant Diagnostics market has been segmented as below:
By Technology
By Product & Services
By Application
By End-User
By Region
By Company
The report covers the below scope:
The years considered for the study are as follows:
Report Scope:
The global market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers the analysis of regional and country-level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the market share. Major industry players with significant revenue share include Abbott Laboratories Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche, Ltd., Illumina, Inc., Immucor, Inc., Linkage Biosciences, Olerup Ssp Ab, Qiagen N.V., Thermo Fisher Scientific Inc., Sigma-Aldrich, and others.
Why Buy this Report:
Target Audience:
The report targeted the existing players in the industry is as follows:
Free and Paid Customization based on the requirement
Report Content
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5.1 Introduction
5.2 Molecular Assay
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 PCR-based Molecular Assay
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Sequencing-based Molecular Assay
5.4.1 Market Overview
5.4.2 Market Size and Forecast
6.1 Introduction
6.2 Reagents & Consumables
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Instruments
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Software & Services
6.4.1 Market Overview
6.4.2 Market Size and Forecast
7.1 Introduction
7.2 Diagnostic Applications
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Pre-transplantation Diagnostics
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Post-transplantation Diagnostics
7.4.1 Market Overview
7.4.2 Market Size and Forecast
8.1 Introduction
8.2 independent Reference Laboratories
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Hospitals & Transplant Centers
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Research Laboratories & Academic Institutes
8.4.1 Market Overview
8.4.2 Market Size and Forecast
9.1 Introduction
9.2 North America
9.2.1 North America Market, By Technology
9.2.2 North America Market, By Product & Services
9.2.3 North America Market, By Application
9.2.4 North America Market, By End User
9.3 Europe
9.3.1 Europe Market, By Technology
9.3.2 Europe Market, By Product & Services
9.3.3 Europe Market, By Application
9.3.4 Europe Market, By End User
9.4 Asia-Pacific
9.4.1 Asia-Pacific Market, By Technology
9.4.2 Asia-Pacific Market, By Product & Services
9.4.3 Asia-Pacific Market, By Application
9.4.4 Asia-Pacific Market, By End User
9.5 Rest of the World
9.5.1 Rest of the World Market, By Technology
9.5.2 Rest of the World Market, By Product & Services
9.5.3 Rest of the World Market, By Application
9.5.4 Rest of the World Market, By End User
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
11.1 Abbott Laboratories Inc.
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 Bio-Rad Laboratories Inc.
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 F. Hoffmann-La Roche, Ltd.,
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 Illumina, Inc., Immucor, Inc.
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 Linkage Biosciences
11.5.1 Company Overview
11.5.2 Product/Service Landscape
11.5.3 Financial Overview
11.5.4 Recent Developments
11.6 Olerup Ssp Ab
11.6.1 Company Overview
11.6.2 Product/Service Landscape
11.6.3 Financial Overview
11.6.4 Recent Developments
11.7 Qiagen N.V.,
11.7.1 Company Overview
11.7.2 Product/Service Landscape
11.7.3 Financial Overview
11.7.4 Recent Developments
11.8 Thermo Fisher Scientific Inc.
11.8.1 Company Overview
11.8.2 Product/Service Landscape
11.8.3 Financial Overview
11.8.4 Recent Developments
11.9 Sigma-Aldrich
11.9.1 Company Overview
11.9.2 Product/Service Landscape
&nbs